Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jun 20;10:1101–1113. doi: 10.2147/PPA.S106311

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Nolla et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Pareto diagrams representing patients’ and professionals’ utility values for subcutaneous and intravenous treatment alternatives.

Notes: (A) Utility values for patients regarding subcutaneous treatment. (B) Utility values for patients regarding intravenous treatment. (C) Utility values for professionals regarding subcutaneous treatment. (D) Utility values for professionals regarding intravenous treatment. Duration of effect indicates the time until perceiving the need for a new dose (1 week, 4 weeks, and 8 weeks).

Abbreviations: AEs, adverse events; BA, biological agent.